PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4100
-0.0100 (-2.38%)
Sep 30, 2026, 3:57 PM EST
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 71.37 million as of September 30, 2026. Its market cap has increased by 26.77% in one year.
Market Cap
71.37M
Enterprise Value
52.18M
Revenue
27.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
ChartMarket Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 71.37M, an increase of 2,873.90%. That is a compound annual growth rate of 133.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 71.37M | -6.03% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.20B |
| Curaleaf Holdings | 4.07B |
| Extendicare | 2.91B |
| Green Thumb Industries | 2.39B |
| ME Therapeutics Holdings | 85.09M |
| Leef Brands | 82.50M |
| Helix BioPharma | 80.96M |
| NetraMark Holdings | 69.08M |